Reduced enjoyment of coffee
Combination Studies: Ipamorelin + CJC-1295 (No DAC) is a commonly investigated combination for examining synergistic GH release
Commonly prescribed compounds include semaglutide, tirzepatide (during shortage periods), BPC-157, sermorelin, and ipamorelin
Based on several pivotal trials in T2DM, the NKF KDOQI guidelines recommend intensive glycemic control (HbA1c 53 mmol/mol)[7%] to prevent or delay the progression of albuminuria and other macro and microvascular complications
If side effects dont improve with time or dietary changes, your doctor may suggest lowering your dose or trying an alternative weight loss drug to make it easier to tolerate
Disclaimer: Ozempic, WeGovy, Saxenda and Victoza are registered trademarks of Novo Nordisk